financetom
Business
financetom
/
Business
/
Jio enters agreement with Airtel to use 800 MHz spectrum in 3 circles
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Jio enters agreement with Airtel to use 800 MHz spectrum in 3 circles
Apr 6, 2021 8:05 AM

Telecom major Reliance Jio on Tuesday signed an agreement with rival Bharti Airtel for the right to use spectrum in the 800 MHz band in Delhi, Mumbai and Andhra Pradesh circles.

The agreement will enhance Jio's network capacity in these circles. Through the agreement -- which is subject to statutory approvals -- Jio will buy spectrum for Rs 1,497 crore and assume liabilities of Rs 459 crore.

"The aggregate value for the right to use this spectrum is Rs 1,497 crores, inclusive of the present value of associated deferred payment liability of Rs 459 crores, subject to any transaction related adjustments," Reliance Jio said on Tuesday.

"The trading agreement is in accordance with the Spectrum Trading Guidelines issued by the Department of Telecommunications and is subject to the requisite regulatory and statutory approvals," it added.

In the spectrum auction held early in March, Jio had acquired the maximum spectrum, i.e. 488.35 MHz across three circles, for Rs 57,122.65 crore in the latest round of auction. In the same auction, Bharti Airtel had acquired 355.45 MHz spectrum across Sub-GHz, mid-band and 2300 MHz bands, for Rs 18,699 crore and Vodafone Idea spent Rs 1993.40 crore for 11.8 MHz spectrum across five circles.

Disclosure:

Network18, the parent company of CNBCTV18.com, is controlled by Independent Media Trust, of which Reliance Industries is the sole beneficiary.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US FDA approves Novo Nordisk's Ozempic to reduce diabetic kidney disease progression
US FDA approves Novo Nordisk's Ozempic to reduce diabetic kidney disease progression
Jan 28, 2025
Jan 28 (Reuters) - Novo Nordisk said on Tuesday the U.S. FDA has approved its blockbuster drug Ozempic to lower the risk of progression of chronic kidney disease and the organ's failure, and death due to heart problems in adults with type 2 diabetes. Ozempic belongs to a class of drugs known as GLP-1 receptor agonists and has the same...
Market Chatter: Nvidia Short Sellers Amass $6.6 Billion in Profits Amid Frenzy Over DeepSeek
Market Chatter: Nvidia Short Sellers Amass $6.6 Billion in Profits Amid Frenzy Over DeepSeek
Jan 28, 2025
03:06 PM EST, 01/28/2025 (MT Newswires) -- Bets against Nvidia ( NVDA ) amid a surge in interest for Chinese artificial intelligence app DeepSeek yielded one-day gains of about $6.6 billion for short sellers, Reuters reported Tuesday, citing data analytics firm Ortex. Short positions in Broadcom ( AVGO ) resulted in more than $2 billion in profits, the report added....
Tower Semiconductor Analyst Sees 'Attractive' Buying Opportunity Following DeepSeek Selloff
Tower Semiconductor Analyst Sees 'Attractive' Buying Opportunity Following DeepSeek Selloff
Jan 28, 2025
Benchmark analyst Cody Acree named Tower Semiconductor ( TSEM ) Inc. among recommended oversold names following Monday’s market rout, which was triggered by DeepSeek’s announcement of its advanced language model. Monday’s Selloff: Chinese AI lab DeepSeek unveiled a new large language model reportedly meeting or exceeding leading competitors’ performance at a fraction of the cost. The claims, though met with...
--MGIC Investment Keeps Quarterly Dividend at $0.13 a Share, Payable March 5 to Holders on Feb. 18
--MGIC Investment Keeps Quarterly Dividend at $0.13 a Share, Payable March 5 to Holders on Feb. 18
Jan 28, 2025
03:13 PM EST, 01/28/2025 (MT Newswires) -- Price: 25.49, Change: -0.09, Percent Change: -0.37 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved